Brian Ritchie | LifeSci Advisors |
Sergio Traversa | Chief Executive Officer |
John Hixon | Head of Commercial |
Maged Shenouda | Chief Financial Officer |
Andrew Tsai | Jefferies |
Yatin Suneja | Guggenheim |
Andrea Tan | Goldman Sachs |
Joon Lee | Truist Securities |
Jay Olson | Oppenheimer |
Uy Ear | Mizuho Securities |
Good day, ladies and gentlemen, and welcome to the Relmada Therapeutics, Inc.
Second Quarter 2022 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Brian Ritchie of LifeSci Advisors. Please go ahead, sir.